INTS

INTENSITY THERAPEUTICS, INC.

Healthcare · Biotechnology

$86.77 sample

+0.67 (+0.78%) 1D

Market cap

$236.3B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-29

Alerts

8

Price$86.77 +1.88% 3M daily closessample

88.4080.96

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider buy: Director
Sep 29SECForm 144 filed
Sep 22INSInsider buy: Chief Financial Officer
Sep 16INSInsider sell: Chief Financial Officer
Sep 11INSInsider sell: General Counsel
Sep 04INSInsider sell: Director
Aug 31SEC8-K filed: material event
Aug 21INSInsider sell: Director

Sign up to see the real INTS record →

Company facts

SEC EDGAR registration

Name: INTENSITY THERAPEUTICS, INC.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -54sample, -100 to +100
Reporting currency: USD

Who is positioning in INTS

sample

Insiders: 6 insider transactions over 90 days, net selling, $739.2M
Congress: 4 members traded over 90 days
Institutions · 13F: 33 funds hold $1.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$12.6B +12.6% y/y

Q4 2024Q3 2026

Inventory$7.3B +12.5% y/y

Q4 2024Q3 2026

Accounts receivable$5.5B +11.4% y/y

Q4 2024Q3 2026

Total debt$15.3B +11.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $146.2B -9.4% 3M
Sample peer B: $32.1B +9.0% 3M
Sample peer C: $150.8B -6.6% 3M
Sample peer D: $67.0B -10.7% 3M
Sample peer E: $122.9B +14.8% 3M